Human CD20 Protein-VLP, Accession: P11836

/在： /经由过程：
  • 产物概述
  • 产物规格
  • 运输及存储
  • 品牌申明

    • 产物概述

    产物描写

    Recombinant Human CD20 Protein-VLP is expressed from HEK293.It contains Met1-Pro297.

    Biotinylated

    产物规格

    靶点

    CD20 VLP

    份子又名

    MS4A1; CD20; MS4A-1; B1; Bp35; CD20 receptor; CD20S7; CVID5; LEU-16; Ly-44; MS4A2; S7

    Accession

    种属

    Human

    卵白序列

    Met1-Pro297

    份子量

    The target protein has a predicted MW of 34.3 kDa.

    活性

    Immobilized Human CD20 VLP at 5ug/ml (100ul/Well) on plate on the plate. Dose response curve for Rituximab, hFc Tag with the EC50 of 8.7ng/ml determined by ELISA (QC Test). See testing image for detail.

    产物标签

    抒发体系

    HEK293

    纯度

    > 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产物表面

    Lyophilized

    运输前提

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.Notice: If you need it for immunization, Do Not use any adjuvant.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和不变性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 该终产物的品牌标志ChemWhat是Watson的注测品牌，由Watson受权福建海角社区 在国内 内地省份回收利用，点此拜候。